As part of the Rare Hematology/Endocrine franchise, the US Sickle Cell Team aims to meaningfully improve the lives and treatment of individuals living with Sickle Cell. The Sickle Cell Portfolio represents a growth opportunity for Specialty Care and Pfizer, with one asset in phase 3 development (osivelotor) and one previously marketed product (Oxbryta) currently under regulatory review. The Sickle Cell Launch and Access Integration Lead will be a critical leader for the US Sickle Cell Disease portfolio. This individual will play a key role by helping to develop, coordinate and execute an overarching go-to-market strategy by thoroughly understanding the sickle cell disease patient journey and partnering with cross-functional partners to enable access and ensure adherence to medication as appropriate. In addition, this role will be responsible for core strategic activities including operating/brand planning lead and overseeing product launch activities in partnership with Global and cross functional colleagues. This role requires the ability to prioritize in order to advance key portfolio imperatives that aim to maximize patient access and adherence within a unique and dynamic landscape. This role is critical in developing and managing compliant resources, strategies and solutions to educate, enhance the patient experience and improve access to therapy. In addition, this role requires strong strategic and analytical skills, a passion for supporting patients, a problem-solving mindset, focus on innovation and a proven track record of exceptional cross-functional collaboration and leadership. This position reports to the Senior Director, US Sickle Cell Disease Marketing Team Lead.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level